Piper Sandler Maintains Overweight on Aspen Aerogels, Lowers Price Target to $33
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Alexander Potter maintains an Overweight rating on Aspen Aerogels (NYSE:ASPN) but lowers the price target from $36 to $33.
October 22, 2024 | 2:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Piper Sandler has maintained its Overweight rating on Aspen Aerogels but reduced the price target from $36 to $33, indicating a slightly less optimistic outlook.
The maintenance of an Overweight rating suggests continued confidence in Aspen Aerogels' performance, but the lowered price target indicates a tempered outlook. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100